Search research articles
Contact Us
Filters
Showing results (211-220 of 369) with videos related to
Page
of 37
Sort By:
Cancer Research
|
December 1, 1993
cis-diamminedichloroplatinum(ii) resistance in vitro and in vivo in human embryonal carcinoma cells
H Timmer-Bosscha, A Timmer, C Meijer, et al.
Cancer Research
|
December 15, 1993
Pharmacokinetics of recombinant human interleukin 3 administered subcutaneously and by continuous intravenous infusion in patients after chemotherapy for ovarian cancer
B Biesma, R Pokorny, J M Kovarik, et al.
Cancer Gene Therapy
|
August 5, 2000
Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors
R Dummer, J Bergh, Y Karlsson, et al.
Anticancer Research
|
August 6, 2000
Retargeting of a T cell line by anti MAGE-3/HLA-A2 alpha beta TCR gene transfer
A Calogero, G A Hospers, K M Krüse, et al.
Pharmaceutical Research
|
September 1, 1994
Effect of ultrafilterable platinum concentration on cisplatin and carboplatin cytotoxicity in human tumor and bone marrow cells in vitro
H J Guchelaar, E G de Vries, C Meijer, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1986
Pharmacokinetics of high dose etoposide (VP 16-213)
J J Holthuis, P E Postmus, W J Van Oort, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1989
A phase I pharmacokinetic study of 21-day continuous infusion mitoxantrone
J Greidanus, E G de Vries, N H Mulder, et al.
Blut
|
August 1, 1983
Lymphocyte characteristics and function in paroxysmal nocturnal haemoglobinuria
E Vellenga, G J Ensing, M R Halie, et al.
Cancer Research
|
January 1, 1991
A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma
E G de Vries, B Biesma, P H Willemse, et al.
British Journal of Cancer
|
May 1, 1993
Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response
A Martens, R A Janssen, D T Sleijfer, et al.
Page
of 37
Search research articles
Search
Showing results (211-220 of 369) with videos related to
Sort By:
Page
of 37
Cancer Research
|
December 1, 1993
cis-diamminedichloroplatinum(ii) resistance in vitro and in vivo in human embryonal carcinoma cells
H Timmer-Bosscha, A Timmer, C Meijer, et al.
Cancer Research
|
December 15, 1993
Pharmacokinetics of recombinant human interleukin 3 administered subcutaneously and by continuous intravenous infusion in patients after chemotherapy for ovarian cancer
B Biesma, R Pokorny, J M Kovarik, et al.
Cancer Gene Therapy
|
August 5, 2000
Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors
R Dummer, J Bergh, Y Karlsson, et al.
Anticancer Research
|
August 6, 2000
Retargeting of a T cell line by anti MAGE-3/HLA-A2 alpha beta TCR gene transfer
A Calogero, G A Hospers, K M Krüse, et al.
Pharmaceutical Research
|
September 1, 1994
Effect of ultrafilterable platinum concentration on cisplatin and carboplatin cytotoxicity in human tumor and bone marrow cells in vitro
H J Guchelaar, E G de Vries, C Meijer, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1986
Pharmacokinetics of high dose etoposide (VP 16-213)
J J Holthuis, P E Postmus, W J Van Oort, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1989
A phase I pharmacokinetic study of 21-day continuous infusion mitoxantrone
J Greidanus, E G de Vries, N H Mulder, et al.
Blut
|
August 1, 1983
Lymphocyte characteristics and function in paroxysmal nocturnal haemoglobinuria
E Vellenga, G J Ensing, M R Halie, et al.
Cancer Research
|
January 1, 1991
A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma
E G de Vries, B Biesma, P H Willemse, et al.
British Journal of Cancer
|
May 1, 1993
Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response
A Martens, R A Janssen, D T Sleijfer, et al.
Page
of 37